Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiodermatitis × dimethicone × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiodermatitis 1 Dermatitis 1 Breast Neoplasms 1

Interventions

Low-Level Light Therapy 5 Petrolatum 2 dimethicone 1 Triamcinolone Acetonide 1 Thioctic Acid 1 Standard of Care 1 Silver Sulfadiazine 1 Radiotherapy, Conformal 1 Radiotherapy 1 Practice Guidelines as Topic 1 Melatonin 1 Laser Therapy 1 Hydrogel, Polyethylene Glycol Dimethacrylate 1 Hydrocortisone 1 Dimethyl Sulfoxide 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02534129 2017-10-06

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

ProTechSure Scientific, Inc.

Phase 1/2 Terminated

13 enrolled 3 charts

Breast Neoplasms, Dermatitis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡